Potential role of PKC inhibitors in the treatment of hematological malignancies
The serine/threonine protein kinase C (PKC) family, the main target of tumor-promoting phorbol esters, is functionally associated to cell cycle regulation, cell survival, malignant transformation, and tumor angiogenesis. Although PKC isozymes represent an attractive target for novel anticancer thera...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2008
|
| Online Access: | http://hdl.handle.net/20.500.11937/30155 |